相关实验视频
Updated: Mar 1, 2026

10:49
Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
7.1K
在患有神经退行性痴呆症的患者中,短串重复扩张
Yuan Zhu1, Xuewen Xiao1, Yiliang Liu1
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
EBioMedicine
|February 28, 2026
概括
短串重复 (STR) 扩展与神经退行性痴呆症 (NDD) 有关. 这项研究在2.12%的NDD病例中发现了致病性STR扩散,突出了它们在疾病发展中的作用.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 基因组医学是基因组医学.
背景情况:
- 诊断神经退行性痴呆 (NDD) 像阿尔茨海默病 (AD) 是具有挑战性的,因为重叠的症状.
- 短串重复 (STR) 扩张已知是各种痴呆症的原因,但大规模研究有限.
研究的目的:
- 系统地调查NDD患者的大队伍中致病性STR扩散的患病率和影响.
- 确定与不同类型的NDD相关的特定STR.
主要方法:
- 使用ExpansionHunter (EH) 分析了来自1559名NDD患者和1522名对照者的全基因组测序 (WGS) 数据.
- 评估了22种与神经退行性疾病相关的STR,通过重复原始聚合酶连锁反应 (RP-PCR) 进行验证.
- 使用ExpansionHunter Denovo (EHDn) 来改善C9orf72扩张的检测.
主要成果:
- 在1559名NDD患者的9个基因中发现了33种致病性STR扩张,占病例的2.12%.
- 致病性STR扩张与NDD状态显著相关 (OR = 3.57).
- 中长度TBP等位基因在渐进性上核麻 (PSP) 病例中显示出显著的丰富性.
结论:
- STR扩张在临床上是类的,在NDD的发病过程中发挥着重要作用.
- 这项研究为痴呆症的原因提供了关键的遗传洞察力,有助于诊断工作.
更多相关视频
08:53Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
9.2K
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
8.5K
相关概念视频
Comparing Copy Number Variations and SNPs
18.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.9K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K